London (AP) — The first shot of coronavirus vaccination could stalemate 60 countries, including the poorest in the world. This is because almost all distribution by global programs aimed at supporting the coronavirus will be blocked until June.
COVAX is a global initiative to provide vaccines to countries that are unable to negotiate shortage supplies on their own, shipping more than 25,000 vaccines to low-income countries only twice a day last week. .. Delivery has almost stopped since Monday.
Last 2 weeks According to data edited daily by UNICEFThe total dose of COVAX cleared for shipment to 92 developing countries is less than 2 million, the same as the amount injected in the UK alone.
On Friday, the head of the World Health Organization condemned the “shocking imbalance” of global COVID-19 vaccination. WHO Secretary-General Tedros Adhanom Gebreisas said that one in four developed countries was vaccinated, while poorer ones were vaccinated.
Vaccine shortage is mainly India decision Stop exporting vaccines from the Serum Institute factory. The plant produces the overwhelming majority of AstraZeneca’s dose, which COVAX expected to supply about one-third of the world’s population at one time. Coronavirus is on the rise all over the world.
COVAX ships only vaccines approved by WHO, and countries are becoming more and more impatient. Supply is declining in some of the countries that first received COVAX shipments, and the expected delivery of a second dose in the currently recommended 12-week window is currently questioned. In a statement, the Vaccine Alliance, known as GAVI, said 60 countries were affected by the Associated Press delay.
At the vaccination tents at Kenyatta National Hospital in Nairobi, many who arrived for the first jab were worried about when the second jab would arrive.
“I’m afraid that if I don’t take a second dose, my immunity may be weakened and I may die,” said civil servant Oscar Odinga.
Internal WHO documents obtained by the AP indicate that delivery uncertainties “have lost confidence in COVAX (efforts) in some countries.” As a result, WHO is considering expediting the approval of vaccines from China and Russia, which have not been approved by European and North American regulators.
According to WHO documents, UN agencies have stated that in addition to “uncertainty as to whether all persons vaccinated in the first round will be guaranteed a second vaccination”, COVAX participants will be assigned. Faced with the question.
WHO refused to specifically address the issues raised in the internal sources, but previously countries were “very enthusiastic” to get the vaccine as soon as possible and did not hear any complaints about the process. Insisted.
Concerns about links between AstraZeneca shots and rare blood clots “We are nervous about both safety and efficacy,” WHO said. Among the proposed solutions is a decision from China and Russia to “promote the review of additional products”.
WHO said last month that it might be able to shed light on Chinese vaccines by the end of April.
Some experts point out that the two Chinese-made vaccines, Sinopharm and Sinovac, have no published data and there are reports of people who need a third dose to protect them.
“If you miss something because you didn’t thoroughly assess the risk of serious adverse events with these vaccines, you’ll find that it’s safe for all the good products you’re using It’s a loss of trust, “said director Dracary. Assessment of health fairness and rights at CARE International.
Other experts were concerned that delays could undermine government credibility. Vaccination program And soon I was relying on the second dose.
Lavanya Vasudevan, an assistant professor at Duke University’s Global Health Institute, said: “Every day the virus is in circulation is an opportunity for the virus to mutate into a more deadly variant.”
Earlier this month, WHO advanced to urgently share 10 million doses to meet the UN goal of starting COVID-19 vaccination in all countries within the first 100 days of the year. I called on the country. So far, countries have promised COVAX hundreds of millions of dollars. However, there are no doses to buy and no country has agreed to share what they have immediately.
Bilateral donation of dose Tends to go along the political line, Not the most infected country, and not enough to supplement the goals set by the COVAX. Think about global healthA data site managed by the Council on Foreign Relations identified 19 countries that provided a total of 27.5 million doses to 102 countries as of Thursday.
Thomas Bollyky, Director of the Council on Foreign Relations’ Global Health Program, said: Bollyky said COVAX is a big disappointment and the only option available in most of the world.
According to the Japan Disaster Relief Team, COVID-19 cases and deaths surged last month in many endangered countries. It was 322% in Kenya, 379% in Yemen and 529% in northeastern Syria.
On Thursday, the agencies behind COVAX (WHO, Vaccine Alliance GAVI and Coalition for Epidemic Control CEPI) celebrated delivering 38 million life-saving vaccines to more than 100 countries.
Brook Baker, a vaccine expert at Northeastern University, said the message of praise was irrelevant.
“Celebrating enough doses for just 19 million people, or 0.25% of the world’s population, is deaf,” he said, adding that it was time for WHO and its partners to become more honest with the country.
“WHO and GAVI have repeatedly over-promised and under-delivered, so why should we believe that we can suddenly increase production and delivery in a few months?” He said.
Outside the Nairobi vaccination tent on Thursday, infectious disease doctor Dr. Duncan Nukli sought to reassure people to take their first dose.
“If you take the first dose and fail the second dose, it doesn’t mean that you’re weakened or at increased risk of getting infected,” he said. The body will develop some immunity to coronavirus infection. However, this immunity is not as good as those who received both doses. “
Hinant reported from Paris. Contributed by Khaled Kazziha in Nairobi, Kenya.
Follow AP’s pandemic coverage below.